[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amphastar Pharma (AMPH)

Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 863,947
  • Shares Outstanding, K 42,538
  • Annual Sales, $ 719,890 K
  • Annual Income, $ 98,090 K
  • EBIT $ 114 M
  • EBITDA $ 174 M
  • 60-Month Beta 0.89
  • Price/Sales 1.23
  • Price/Cash Flow 4.88
  • Price/Book 1.19

Options Overview Details

View History
  • Implied Volatility 81.73% (-5.18%)
  • Historical Volatility 38.77%
  • IV Percentile 69%
  • IV Rank 39.74%
  • IV High 151.74% on 03/23/26
  • IV Low 35.55% on 08/18/25
  • Expected Move (DTE 10) 1.02 (5.00%)
  • Put/Call Vol Ratio 2.00
  • Today's Volume 6
  • Volume Avg (30-Day) 113
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 2,256
  • Open Int (30-Day) 1,698
  • Expected Range 19.40 to 21.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.70
  • Number of Estimates 2
  • High Estimate $0.73
  • Low Estimate $0.67
  • Prior Year $0.83
  • Growth Rate Est. (year over year) -15.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.41 +10.92%
on 07/14/26
22.65 -9.83%
on 08/07/26
+1.70 (+9.08%)
since 07/10/26
3-Month
16.65 +22.68%
on 05/18/26
22.65 -9.83%
on 08/07/26
+1.97 (+10.68%)
since 05/11/26
52-Week
16.65 +22.68%
on 05/18/26
31.26 -34.69%
on 09/02/25
-6.94 (-25.37%)
since 08/11/25

Most Recent Stories

More News
AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results

AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results

AMPH : 20.42 (+0.54%)
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026

Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026

AMPH : 20.42 (+0.54%)
Amphastar: Q2 Earnings Snapshot

Amphastar: Q2 Earnings Snapshot

AMPH : 20.42 (+0.54%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2026

RANCHO CUCAMONGA, Calif. , Aug. 6, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) ("Amphastar" or the "Company"), a biopharmaceutical company focused on developing, manufacturing,...

AMPH : 20.42 (+0.54%)
Amphastar's Earnings Call Will Reveal Whether the Estimate Collapse Was Justified

Barchart Research What to Expect from AMPH Earnings AMPH Generated August 5, 2026 Current Price $20.24 EPS Estimate $$0.51 Consensus Rating Hold Average Move 11.64% Amphastar's Earnings Call Will Reveal...

AMPH : 20.42 (+0.54%)
What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings

What To Expect From Amphastar Pharmaceuticals’s (AMPH) Q2 Earnings

AMPH : 20.42 (+0.54%)
1 Value Stock to Own for Decades and 2 Facing Challenges

1 Value Stock to Own for Decades and 2 Facing Challenges

EXLS : 34.90 (-0.48%)
AMPH : 20.42 (+0.54%)
AMCX : 11.79 (-0.51%)
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026

RANCHO CUCAMONGA, Calif. , July 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its second quarter of 2026 ended...

AMPH : 20.42 (+0.54%)
1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds

1 Profitable Stock with Impressive Fundamentals and 2 Facing Headwinds

LSCC : 126.12 (-1.71%)
RELY : 23.61 (+2.03%)
AMPH : 20.42 (+0.54%)
3 Reasons AMPH is Risky and 1 Stock to Buy Instead

3 Reasons AMPH is Risky and 1 Stock to Buy Instead

AMPH : 20.42 (+0.54%)

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

3rd Resistance Point 21.23
2nd Resistance Point 20.90
1st Resistance Point 20.66
Last Price 20.42
1st Support Level 20.09
2nd Support Level 19.76
3rd Support Level 19.52

See More

52-Week High 31.26
Fibonacci 61.8% 25.68
Fibonacci 50% 23.95
Fibonacci 38.2% 22.23
Last Price 20.42
52-Week Low 16.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.